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Neisseria meningitidis (Nm) urogenital infections, although less 
common than infections caused by Neisseria gonorrhoeae (Ng), 
have been associated with urethritis, cervicitis, proctitis, and 
pelvic inflammatory disease. Nm can appear similar to Ng on 
Gram stain analysis (gram-negative intracellular diplococci) 
(1–5). Because Nm colonizes the nasopharynx, men who 
receive oral sex (fellatio) can acquire urethral Nm infections 
(1,3,5). This report describes an increase in Nm-associated 
urethritis in men attending sexual health clinics in Columbus, 
Ohio, and Oakland County, Michigan.
The Columbus and Oakland County clinics are two of the 
sites participating in CDC’s Gonococcal Isolate Surveillance 
Project,* through which urethral isolates from the first 25 men 
evaluated each month with Ng urethritis undergo antibiotic 
susceptibility testing. At both clinics, staff members obtain 
urethral swabs from men for Gram stain and culture, and urine 
for nucleic acid amplification testing (NAAT) for Ng. During 
January–November 2014, Columbus documented no cases of 
presumed Nm urethritis (i.e., urethral gram-negative intracel-
lular diplococci, growth of oxidase-positive bacterial colonies 
on modified Thayer-Martin media, and negative urine NAAT 
for Ng). However, two presumed cases occurred in December 
2014. During January–September 2015, a total of 52 cases 
of urethritis were confirmed to be caused by Nm by Analytic 
Profile Index Neisseria-Haemophilus (API NH) (BioMérieux) 
testing and sodC polymerase chain reaction (PCR). Using the 
same criteria, Oakland County had documented two cases of 
Nm urethritis in 2013, eight cases in 2014, and 15 cases during 
January–October 2015.
Fifty-two urethral Nm isolates from Columbus and 12 
from Oakland County were sent to CDC for molecular 
characterization. All Columbus isolates were non-groupable by 
slide agglutination serogrouping and serogroup specific PCR. 
Multilocus sequence typing demonstrated that all isolates were 
ST-11 and part of the CC-11/ET-37 clonal complex. Eleven 
of the 12 Oakland County isolates exhibited the same genetic 
profile as the Columbus isolates.
Demographic characteristics of the Columbus and Oakland 
County patients were similar (Table). Median age of the 
Columbus patients was 30.0 years (interquartile range = 24.5–
39.0 years); median age of the Oakland County patients was 
29.0 years (interquartile range = 18.0–47.0 years). Among all 
patients, 99% reported heterosexual orientation, and 97% 
had symptomatic urethritis. Oral sex was reported by 100% 
of Columbus patients (data on receipt of fellatio was not avail-
able) and 93% of Oakland County patients (100% received 
fellatio). Among Columbus patients, 84% reported two or 
more sex partners in the preceding 90 days, whereas 56% of 
Oakland County patients reported two or more partners in the 
preceding 60 days. Five Columbus patients reported out of state 
travel during the preceding 60 days, including to New York, 
Chicago, Miami, Philadelphia, and West Virginia. Travel infor-
mation was unavailable for Oakland County patients. Based 
on urethral Gram stain results, 90% of patients were treated 
for presumed Ng infection with the CDC-recommended 
regimen (6), which is also appropriate treatment for Nm ure-
thritis. Vaccination data for the patients were incomplete, but 
meningococcal vaccination was documented in five Columbus 
patients (received during 2007–2012) and three Oakland 
County patients (received during 2007–2009).
Cases of urethritis caused by a clonal strain of Nm (non-
groupable, ST-11 and CC-11/ET-37) are occurring among 
primarily heterosexual men seeking sexual health services in 
Columbus, Ohio, and Oakland County, Michigan. Because the 
strain appears to be spreading sexually, increased awareness is 
warranted. Clinicians should treat Nm urethritis as they would 
treat Ng urethritis (a single 250-mg dose of intramuscular 
ceftriaxone plus a single 1-g oral dose of azithromycin) (6). 
Until more data are available on transmission and sequelae, 
sex partners of patients with Nm urethritis should be treated as 
they would be for exposure to urogenital Ng. Increases in Nm 
urethritis cases above baseline should be reported to CDC via 
e-mail, nmurethritis@cdc.gov (protected health information 
should not be sent to this e-mail).
* https://www.cdc.gov/std/gisp/gisp-protocol-may-2016.pdf.
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TABLE. Characteristics of men with confirmed urethral Neisseria meningitidis infection at two sentinel clinics — Gonococcal Isolate Surveillance 
Project, Columbus, Ohio, and Oakland County, Michigan, 2015
Characteristic
Columbus (N = 52) Oakland County (N = 15)
No. (%) No. (%)
Race
White 7 (13) 0 (—)
Black 44 (85) 15 (100)
Asian 0 (—) 0 (—)
Other 1 (2) 0 (—)
Ethnicity
Non-Hispanic 52 (100) 15 (100)
Hispanic 0 (—) 0 (—)
Sexual orientation
Heterosexual 52 (100) 14 (93)
Homosexual 0 (—) 0 (—)
Bisexual 0 (—) 1 (7)
Symptoms
Discharge and/or dysuria 51 (98) 14 (93)
No discharge or dysuria 1 (2) 0 (—)
Balanitis 0 (—) 1 (7)
History of self-reported or confirmed episode of previous Neisseria gonorrhoeae infection (lifetime)
Yes 27 (52) 5 (33)
No 25 (48) 10 (67)
No. of confirmed episodes of N. gonorrhoeae infection (preceding12 months)
One 14 (27) 1 (7)
Two 2 (4) 0 (—)
Three or more 1 (2) 0 (—)
No documented previous episodes 34 (65) 14 (93)
Unknown 1 (2) 0 (—)
Most recent HIV status
Positive (documented or self-reported) 1 (2) 0 (—)
Negative (documented in preceding 3 months) 51 (98) 15 (100)
Exchange sex for drugs or money*
Yes 8 (15) 0 (—)
No 43 (83) 15 (100)
Unknown 1 (2) 0 (—)
Any injection drug use*
Yes 1 (2) 0 (—)
No 48 (92) 15 (100)
Unknown 3 (6) 0 (—)
Any noninjection recreational drug use, excluding alcohol (preceding 60 days)†
Yes 20 (38) 10 (67)
No 29 (56) 5 (33)
Unknown 3 (6) 0 (—)
Any antibiotic use (preceding 60 days)
Yes 2 (4) NC
No 42 (81) NC
Unknown 8 (15) NC
Treatment provided§
Ceftriaxone plus azithromycin 47 (90) 13 (87)
Ceftriaxone plus doxycycline 2 (4) 1 (7)
Ceftriaxone alone 0 (—) 0 (—)
Azithromycin alone 2 (4) 1 (7)
Unknown 1 (2) 0 (—)
Urethral coinfection with Chlamydia trachomatis by NAAT
Positive 10 (19) 0 (—)
Negative 42 (81) 15 (100)
Abbreviations: HIV = human immunodeficiency virus; NAAT = nucleic acid amplification testing; NC = not collected.
* During the preceding 60 days for Columbus cases and preceding 12 months for Oakland County cases.
† Might include drugs such as ecstasy, methamphetamines, crack, cocaine, marijuana, and poppers.
§ Primary treatment for presumed N. gonorrhoeae infection.
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